IXICO (PHYOF) ROC (Joel Greenblatt) %: -221.45% (As of Mar. 2026)


PHYOF IXICO PLC PHYOF
42 GF Score
Price $0.07
GF Value $0.07
! 2 Warning Signs
View Full Analysis

What is IXICO ROC (Joel Greenblatt) %?

IXICO PHYOF -53.33% 42 ROC (Joel Greenblatt) % is -221.45% as of Mar. 2026. GuruFocus rates PHYOF with a GF Score™ of 42/100 and a GF Value™ of $0.07. The stock has 2 warning signs investors should review. Among 1,324 Biotechnology companies, IXICO ranks better than 52.19% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. IXICO's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -221.45%.

The historical rank and industry rank for IXICO's ROC (Joel Greenblatt) % or its related term are showing as below:

PHYOF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1133.97   Med: -155.5   Max: 186.26
Current: -243.98

During the past 13 years, IXICO's highest ROC (Joel Greenblatt) % was 186.26%. The lowest was -1133.97%. And the median was -155.50%.

PHYOF's ROC (Joel Greenblatt) % is ranked better than
52.19% of 1324 companies
in the Biotechnology industry
Industry Median: -297.06 vs PHYOF: -243.98

IXICO's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


IXICO  (OTCPK:PHYOF) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


IXICO ROC (Joel Greenblatt) % Related Terms


IXICO ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for IXICO's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IXICO ROC (Joel Greenblatt) % Chart

IXICO Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.58 40.82 -100.40 -222.97 -319.53

IXICO Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -260.17 -86.94 -171.43 -420.04 -221.45

PHYOF vs VRTX, REGN, ALNY: ROC (Joel Greenblatt) % Comparison

For the Biotechnology subindustry, IXICO's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IXICO ROC (Joel Greenblatt) % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IXICO's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where IXICO's ROC (Joel Greenblatt) % falls into.


PHYOF
42GF Score
IXICO PLC PHYOF
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IXICO ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.968 + 0 + 1.082) - (0.226 + 0 + 2.353)
=0.471

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.889 + 0 + 1.687) - (2.257 + 0 + 0)
=2.319

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of IXICO for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-4.202/( ( (0.226 + max(0.471, 0)) + (0.779 + max(2.319, 0)) )/ 2 )
=-4.202/( ( 0.697 + 3.098 )/ 2 )
=-4.202/1.8975
=-221.45 %

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -221.45% mean?
IXICO (PHYOF) has a ROC (Joel Greenblatt) % of -221.45% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on IXICO and its competitors. According to the industry distribution chart, IXICO ranks #633 out of 1324 companies in the Biotechnology industry, placing it in the top 47.8%.
Is IXICO's ROC (Joel Greenblatt) % too high?
IXICO's current ROC (Joel Greenblatt) % is -221.45%. Based on the distribution chart, IXICO ranks #633 out of 1324 companies in the Biotechnology industry, which is above the industry midpoint. Overall, IXICO has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does IXICO's ROC (Joel Greenblatt) % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, IXICO ranks #633 out of 1324 companies for ROC (Joel Greenblatt) %. This puts IXICO in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Biotechnology company?
A good ROC (Joel Greenblatt) % depends on the Biotechnology industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on IXICO and its competitors. IXICO's current ROC (Joel Greenblatt) % is -221.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IXICO stock overvalued right now?
IXICO (PHYOF) has a current ROC (Joel Greenblatt) % of -221.45%. The stock's GF Value™ is $0.07, compared to a current price of $0.07 — trading right at its estimated fair value. The current ROC (Joel Greenblatt) % is -221.45%. IXICO's overall GF Score™ is 42/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For IXICO (PHYOF), the current ROC (Joel Greenblatt) % is -221.45% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IXICO (PHYOF) Overvalued in 2026?

Based on GuruFocus' analysis, IXICO stock appears to be undervalued. The current stock price of $0.07 is trading 0% below its estimated GF Value™ of $0.07.

Key valuation signals for PHYOF:

  • ROC (Joel Greenblatt) %: -221.45%
  • GF Value™: $0.07 vs. price of $0.07 (0% below fair value)
  • GF Score™: 42/100 with 2 warning signs

No single metric tells the full story. See the PHYOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IXICO Business Description

Other Exchanges IXI:UK
Address 15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN
IXICO PLC provides neuroscience imaging and biomarker analytics services, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring. It operates as an imaging contract research organization, supporting clinical trials for neurological disorders by processing and analyzing imaging data. Its platform is used to measure biomarkers associated with diseases such as Alzheimer's, Huntington's, and Parkinson's.
42GF Score

Get the complete analysis for PHYOF

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.07
Price
$0.07
GF Value